229 related articles for article (PubMed ID: 35434847)
1. Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia.
Ono Y; Higashida K; Yoshikura N; Hayashi Y; Kimura A; Iwasaki Y; Yoshida M; Shimohata T
Neuropathology; 2022 Jun; 42(3):232-238. PubMed ID: 35434847
[TBL] [Abstract][Full Text] [Related]
2. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.
Josephs KA; Boeve BF; Duffy JR; Smith GE; Knopman DS; Parisi JE; Petersen RC; Dickson DW
Neurocase; 2005 Aug; 11(4):283-96. PubMed ID: 16093229
[TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
[TBL] [Abstract][Full Text] [Related]
4. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
5. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Boeve B; Dickson D; Duffy J; Bartleson J; Trenerry M; Petersen R
Eur Neurol; 2003; 49(2):72-8. PubMed ID: 12584413
[TBL] [Abstract][Full Text] [Related]
6. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
7. An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
Suzuki Y; Adachi T; Sakuwa M; Sakata R; Takigawa H; Hasegawa M; Hanajima R
Neuropathology; 2022 Oct; 42(5):447-452. PubMed ID: 35811445
[TBL] [Abstract][Full Text] [Related]
8. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.
Rohrer JD; Paviour D; Bronstein AM; O'Sullivan SS; Lees A; Warren JD
Mov Disord; 2010 Jan; 25(2):179-188. PubMed ID: 20077483
[TBL] [Abstract][Full Text] [Related]
10. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death.
Zhang L; Toyoshima Y; Takeshima A; Shimizu H; Tomita I; Onodera O; Takahashi H; Kakita A
Neuropathology; 2021 Jun; 41(3):174-182. PubMed ID: 33205528
[TBL] [Abstract][Full Text] [Related]
11. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
[TBL] [Abstract][Full Text] [Related]
12. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
13. Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
Burrell JR; Ballard KJ; Halliday GM; Hodges JR
J Alzheimers Dis; 2018; 61(2):705-715. PubMed ID: 29254097
[TBL] [Abstract][Full Text] [Related]
14. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Morishima R; Bandoh M; Sunami Y; Isozaki E
Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
[TBL] [Abstract][Full Text] [Related]
15. [A 62-year-old woman presenting with progressive nonfluent aphasia, apraxia of eyelid opening, supranuclear gaze palsy, and asymmetric rigidity].
Suzuki K; Nakamura T; Izawa N; Hashimoto K; Ouchi K; Aiba S; Hirata K
Brain Nerve; 2011 Aug; 63(8):884-9. PubMed ID: 21817180
[TBL] [Abstract][Full Text] [Related]
16. [A 77-year-old man with gait and gaze disturbance].
Ikebe S; Mori H; Sumino S; Takanashi M; Hamano Y; Shirai T; Ohkuma Y; Mizuno Y
No To Shinkei; 2000 Mar; 52(3):269-79. PubMed ID: 10769850
[TBL] [Abstract][Full Text] [Related]
17. [An autopsied case of progressive supranuclear palsy presenting with slow progression and unusually prolonged disease duration].
Iwasaki Y; Mori K; Ito M; Mimuro M; Yoshida M
Rinsho Shinkeigaku; 2012; 52(3):156-60. PubMed ID: 22453039
[TBL] [Abstract][Full Text] [Related]
18. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra.
Sakai K; Yamada M
Neuropathology; 2011 Feb; 31(1):77-81. PubMed ID: 20573028
[TBL] [Abstract][Full Text] [Related]
19. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
[TBL] [Abstract][Full Text] [Related]
20. Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
Fujita K; Matsubara T; Miyamoto R; Sumikura H; Takeuchi T; Maruyama Saladini K; Kawarai T; Nodera H; Udaka F; Kume K; Morino H; Kawakami H; Hasegawa M; Kaji R; Murayama S; Izumi Y
BMC Neurol; 2019 Jul; 19(1):168. PubMed ID: 31319800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
